ImmuONE secures £600k from regional and venture investors to advance human lung testing technology.
The funding round was backed by the Midlands Engine Investment Fund, Mercia Ventures, and Pioneer Group.
ImmuONE is a British biotech startup that develops advanced human lung models for preclinical safety testing. The company provides animal-free alternatives for evaluating drugs, chemicals, and consumer products.
ImmuONE has secured £600k in new funding from the Midlands Engine Investment Fund, Mercia Ventures, and Pioneer Group to advance its animal-free testing alternatives. The latest capital injection brings the company's total funding to £3.5m.
The biotech startup will deploy the fresh funds to enhance its laboratory models, expand into sectors including agriculture and automotive, and grow its team with two new scientific hires. This follows previous growth milestones that included laboratory expansions in Milton Keynes and Stevenage after a £2m round in 2023.
Founded in 2019 out of the University of Hertfordshire, ImmuONE provides tissue models incorporating immune cells to test inhalation safety across pharmaceuticals, consumer goods, and chemicals. The company continues to engage with regulators to establish industry standards for animal-free testing.
From the founder
"Our mission is to help companies avoid unnecessary animal testing and provide more accurate and relevant test results. This latest funding will enable us to continue building our range of tests and assays and use our model for different purposes, across different industries. We will also continue engaging with regulators to adapt industry standards tests to become animal free, and establish ImmuONE as a leading provider."
Abigail Martin
Co-founder at ImmuONE
Investor perspective
"The Midlands Engine Investment Fund supports smaller, innovative businesses across the Midlands looking to grow. It’s great to see ImmuONE thriving and making significant strides within its industry. The follow-on funding will enable the company to advance even further and continue to drive innovation in the industry."
Keira Shepperson
Investment Director, Midlands Engine Investment Fund
Use of funds
- 01Grow the team
- 02Continue product development
- 03Expand into international markets
